TMCnet - World's Largest Communications and Technology Community



Obagi Medical Products Shares Down 11.6% Since SmarTrend's Sell Call (OMPI)
[December 31, 2012]

Obagi Medical Products Shares Down 11.6% Since SmarTrend's Sell Call (OMPI)

Dec 31, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for Obagi Medical Products (NASDAQ:OMPI) on July 25th, 2012 at $15.03. In approximately 5 months, Obagi Medical Products has returned 11.64% as of today's recent price of $13.28.

Obagi Medical Products share prices have moved between a 52-week high of $18.00 and a 52-week low of $8.61 and are now trading 54% above that low price at $13.28 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has remained constant.

Obagi Medical Products, Inc. develops skin care pharmaceuticals. The Company develops prescription topical treatments for premature aging, photo-damage, hyperpigmentation, acne, and soft tissue deficits such as fine lines and wrinkles.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Obagi Medical Products.

Log in and add Obagi Medical Products (OMPI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy